[2026 Outlook] Pharma/BiotechIdentifying Leaders Within an Outperforming Sector
In 1H25, US policy uncertainty—i.e., potential drug tariffs, the most-favored-nation (MFN) pricing proposal, and Inflation Reduction Act (IRA) drug...
358 Views
𝛼SK or SearchENTITY
Roche Holding (ROG SW)
Roche Holding (ROG SW)
112
Analysis
Health Care • United States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
morex